Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
apixaban (eliquis) (1 trial)
autologous adipose-derived mesenchymal stem cells (1 trial)
autologous skin fibroblasts (1 trial)
Ischemia (Phase 2)
Trials (3 total)
Trial APIs (3 total)